The 2025–2026 COVID-19 vaccines include updated formulations targeting the JN.1 and LP.8.1 variants. Changes in booster recommendations, vaccine eligibility, and public health strategies reflect the evolving SARS-CoV-2 landscape.
Video overview on Lipid Nanoparticles (LNPs): https://youtu.be/v_0uqm5ANNs
